RINVOQ

AbbVie Biotechnology Ltd.

Application Filed: 2017-02-01
Trademark Application Details
Trademark Logo RINVOQ

Mark For: RINVOQ® trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders.

Status

2023-12-23 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number87320921
Registration Number5908540
Mark Literal ElementsRINVOQ
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTrademark
Current LocationPUBLICATION AND ISSUE SECTION 2019-10-09
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameCheryl A. Withycombe
Attorney Docket NumberABVT68925
Law Office AssignedN70
Employee NameTHOMAS-RIGGS, LESLIE A

Timeline

2017-02-01Application Filed
2017-06-06Published
2017-06-06Published for Opposition
2019-08-16Date of First Use
2019-08-16Date of Use In Commerce
2019-10-09Location: PUBLICATION AND ISSUE SECTION
2019-11-12Status: Live/Registered
2019-11-12Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-11-12Trademark Registered
2019-11-12Transaction Date
2024-11-12Maintenance Early File Date
2025-11-12Maintenance On Time Date
2026-05-12Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: AbbVie Biotechnology Ltd.
AddressClarendon House 2 Church Street Hamilton BERMUDA HM11
Legal Entity TypeCorporation
Legal Entity StateBERMUDA

Attorney of Record

CHERYL A. WITHYCOMBE
ABBVIE INC.
V377/AP34-2
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
GS0051Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2019-11-12
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2019-10-10
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2019-10-09
STATEMENT OF USE PROCESSING COMPLETE2019-09-21
CASE ASSIGNED TO INTENT TO USE PARALEGAL2019-09-21
USE AMENDMENT FILED2019-08-29
TEAS STATEMENT OF USE RECEIVED2019-08-29
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-07-27
SOU TEAS EXTENSION RECEIVED2019-07-25
SOU EXTENSION 4 GRANTED2019-07-25
SOU EXTENSION 4 FILED2019-07-25
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-02-02
SOU TEAS EXTENSION RECEIVED2019-01-31
SOU EXTENSION 3 GRANTED2019-01-31
SOU EXTENSION 3 FILED2019-01-31
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-08-01
SOU TEAS EXTENSION RECEIVED2018-07-30
SOU EXTENSION 2 GRANTED2018-07-30
SOU EXTENSION 2 FILED2018-07-30
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-01-25
SOU TEAS EXTENSION RECEIVED2018-01-23
SOU EXTENSION 1 GRANTED2018-01-23
SOU EXTENSION 1 FILED2018-01-23
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2017-08-01
PUBLISHED FOR OPPOSITION2017-06-06
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2017-06-06
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2017-05-17
APPROVED FOR PUB - PRINCIPAL REGISTER2017-05-04
ASSIGNED TO EXAMINER2017-04-27
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2017-02-06
NEW APPLICATION ENTERED2017-02-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed